Cross-fund · 4 holders
CRNX
CRINETICS PHARMACEUTICALS IN
CUSIP 22663K107
4
Tracked holders
$748.0M
Aggregate value
18,022,821
Shares
5
Active funds
Funds holding CRNX
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $425.3M | 0.01% | −34,625 | −0.4% |
| BlackRock | Institutional | Q1 2026 | $308.0M | 0.01% | +490,267 | +6.1% |
| Citadel | Multi-Strategy | Q1 2026 | $12.6M | — | +61,714 | +21.7% |
| Millennium | Multi-Strategy | Q1 2026 | $2.3M | — | −237,967 | −79.2% |
| Point72FEAT | Multi-Strategy | Q1 2026 | — | — | −2,337,034 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.